CLINICAL_TRIALS
trial_result
· 2007-11-20
Clinical Trial Update: A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver [Phase 2]
Summary
The document reports the completion of a Phase 2 clinical trial evaluating pemetrexed in patients with advanced metastatic liver cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED